You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Swedish/Danish biotech company 2A Pharma has closed its first financing round and has been granted an exclusive, worldwide license from Medigene for its adeno-associated virus like particles (AAVLPs) technology. 2A Pharma AB, based in Malmö, Sweden with research facilities in Aalborg, DenmarAlready a subscriber Login You have read all…
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA). EGPA is a rare autoimmune disease that can cause damage to multiple organs and tissues. The FDA grants ODD statAlready a subscriber Login You have…
AstraZeneca has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited. The deal will include the expansion of rights to roflumilast (marketed as Daliresp in the US and Daxas in other countries), the only approved oral PDE4 inhibitor Already a subscriber Login You…
AstraZeneca potentially could face billions of dollars in damages if it loses its “pay-to-delay” case currently in US. federal court in Boston. The case involves a 2008 settlement AstraZeneca reached with India’s Ranbaxy Laboratories to hold off on bringing to market a generic of its heaAlready a subscriber Login You have…
